Two Million Preventable Cancer Cases Worldwide

An important landmark study has appeared in The Lancet Oncology asserting that as many as two million new cases of cancer worldwide-- or over 16 percent of all cases -- were caused by infections.

And since they were caused by infections, they are in many ways preventable.

Thus the syllogism says that many cancers are caused by infections. Infections are avoidable. Therefore, some cancers are avoidable.

Cancer related to specific types of infections

Researchers found that the majority of these cancer-causing infections were of the gut, liver, cervix and uterus.

Most of the infection-related cancers are indeed preventable, especially cancers linked to:

  • The bacterium Helicobacter pylori
  • The hepatitis B virus
  • The hepatitis C virus
  • Human papillomaviruses

Between these four avoidable agents, some 95%, or 1.9 million cases of infection-related cancer cases can be found.

The proportion of such cancer cases is some three higher in less developed countries (22.9%) than more developed countries (7.4%).

And within this overall picture there is a huge variation by region: for instance only 3.3% of new cancer cases were due to infection in Australia and New Zealand, compared to 32.7% in sub-Saharan Africa.

Worldwide, cervical cancer and uterine cancer from infection cause about half of the new cancer cases in women.

In men, liver and gut cancers account for over 80% of infection-related new cancer cases in men.

The really unbelievable thing is that there are available vaccines to protect one's self against:

  • Hepatitis B (associated with liver cancer.
  • Human papillomavirus (HPV), associated with cervical cancer.

Meanwhile, some of these cancers-- notably, those caused by H. pylori bacteria, can be cured with antibiotics.

The authors of the study wrote:

"Application of existing public health methods for infection prevention such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide."

Source: Medical News Today

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap